These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 310339
1. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy. Olkowski ZL, McLaren JR, Skeen MJ. Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339 [Abstract] [Full Text] [Related]
4. Cellular immunity in patients with epidermoid cancer of the head and neck. Papenhausen PR, Kukwa A, Croft CB, Borowiecki B, Silver C, Emeson EE. Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881 [Abstract] [Full Text] [Related]
13. Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice. Bruley-Rosset M, Florentin I, Kiger N, Davigny M, Mathé G. Cancer Treat Rep; 1978 Nov; 62(11):1641-50. PubMed ID: 728893 [Abstract] [Full Text] [Related]
14. Transference of cell mediated immunity in patients with head and neck cancer. Vetto RM, Burger DR. Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143 [Abstract] [Full Text] [Related]
15. Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy. White JE, Chen T, Reed R, Mira J, Stuckey WJ, Weatherall T, O'Bryan R, Samson MK, Seydel HG. Cancer Treat Rep; 1982 May; 66(5):1113-20. PubMed ID: 7044532 [Abstract] [Full Text] [Related]
16. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL. Cancer Res; 2005 Dec 01; 65(23):11146-55. PubMed ID: 16322265 [Abstract] [Full Text] [Related]
17. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report. Wanebo HJ, Hilal EY, Pinsky CM, Strong EW, Mike V, Hirshaut Y, Oettgen HF. Cancer Treat Rep; 1978 Nov 01; 62(11):1663-9. PubMed ID: 365322 [Abstract] [Full Text] [Related]
18. A murine model for the immunotherapy of head and neck squamous cell carcinoma. Hier MP, Black MJ, Shenouda G, Sadeghi N, Karp SE. Laryngoscope; 1995 Oct 01; 105(10):1077-80. PubMed ID: 7564839 [Abstract] [Full Text] [Related]
19. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma. Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW, Chatterjee SK. Mol Ther; 2006 Jan 01; 13(1):183-93. PubMed ID: 16125469 [Abstract] [Full Text] [Related]
20. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Yasumura S, Hirabayashi H, Schwartz DR, Toso JF, Johnson JT, Herberman RB, Whiteside TL. Cancer Res; 1993 Mar 15; 53(6):1461-8. PubMed ID: 8443824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]